keyword
https://read.qxmd.com/read/38623664/early-prediction-of-bloodstream-infection-with-complete-blood-count-parameters-an-ex-vivo-human-whole-blood-model
#1
JOURNAL ARTICLE
Seyda Ignak, Ozlem Unay-Demirel, Meral Yuksel
BACKGROUND: Despite the advanced laboratory technologies available today, blood culture is the gold standard method in the diagnosis of bloodstream infections. Automated blood culture devices give blood culture results for laboratories approximately in 2 - 3 days up to 7 days. Moreover, some microorganisms like nonreproducible bacteria, fungi or viruses cannot be produced in culture. Among all samples taken for blood culture on suspicion of infection approximately 10% are determined as positive whereas the false positive rate due to contamination is 5%...
April 1, 2024: Clinical Laboratory
https://read.qxmd.com/read/38621246/infectious-diseases-what-you-may-have-missed-in-2023
#2
JOURNAL ARTICLE
Amena Alhammadi, Rasha Alshawaf, Swati Chavda, Sonya Ramondino, Mindy Schuster
In 2023, published research on COVID-19 remains prominent. The aim of this article is to highlight important developments in infectious disease evidence unrelated to COVID-19 that were published in 2023. The literature was screened for sound new evidence relevant to internal medicine specialists and subspecialists whose focus of practice is not infectious diseases. The highlighted publications relate to various organisms and patient populations. One article provides insight into the updated guidelines for the diagnosis and management of infective endocarditis...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38617074/sequential-time-to-positivity-as-a-prognostic-indicator-in-staphylococcus-aureus-bacteremia
#3
JOURNAL ARTICLE
Isin Y Comba, John Raymond Go, James Vaillant, John C O'Horo, Ryan W Stevens, Raj Palraj, Omar Abu Saleh
BACKGROUND: We aimed to determine the factors associated with sequential blood culture time to positivity (STTP) and validate the previously defined time to positivity (TTP) ratio threshold of 1.5 in predicting adverse disease outcomes and mortality of Staphylococcus aureus bacteremia (SAB). METHODS: We conducted an observational study of adult patients with SAB. The TTP ratio was calculated by dividing the TTP of the second blood culture by that of the first. RESULTS: Of 186 patients, 69 (37%) were female, with a mean age of 63...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38606836/daptomycin-and-ceftaroline-combination-for-the-treatment-of-persistent-methicillin-resistant-staphylococcus-aureus-bloodstream-infections-a-case-series-and-literature-review
#4
JOURNAL ARTICLE
Yazed S Alsowaida, Ahmed Alsolami, Thamer A Almangour
Methicillin-resistant Staphylococcus aureus (MRSA) is challenging to treat due to a lack of guidance for clinicians. The daptomycin and ceftaroline combination is promising for treating persistent MRSA bloodstream infections (BSIs). In this report, we present a case series of 7 patients who failed vancomycin and then were treated with daptomycin and ceftaroline for persistent MRSA BSIs. The median age (IQR) of the included patients was 59 (48-67), with 5 male and 2 female patients. Six patients (85.7%) had a clinical cure for their persistent BSIs...
April 12, 2024: Journal of Chemotherapy
https://read.qxmd.com/read/38590604/blood-stream-infections-causative-agents-antibiotic-resistance-and-associated-factors-in-older-patients
#5
JOURNAL ARTICLE
Hoang-Van Quang, Le-Thi Kim Nhung, Pham-Thi Thanh Thuy, Phan Chau Quyen, Le Bao Huy, Ho Si Dung
BACKGROUND: The rate of multi-drug antibiotic resistance in nosocomial bloodstream infections in elderly patients is increasing. This study examined the data for bloodstream infections to gain a better understanding of bacterial antibiotic resistance. METHODS: This was a retrospective study of 817 patients with the first positive blood culture between January 1, 2016 and December 31, 2019. RESULTS: Moyen's age was 77.4 ± 9.8 years, male (52...
2024: Materia Socio-medica
https://read.qxmd.com/read/38583155/the-3-utr-of-vigr-is-required-for-virulence-in-staphylococcus-aureus-and-has-expanded-through-star-sequence-repeat-insertions
#6
JOURNAL ARTICLE
Daniel G Mediati, William Dan, David Lalaouna, Hue Dinh, Alaska Pokhrel, Keiran N Rowell, Katharine A Michie, Timothy P Stinear, Amy K Cain, Jai J Tree
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are alarmingly common, and treatment is confined to last-line antibiotics. Vancomycin is the treatment of choice for MRSA bacteremia, and treatment failure is often associated with vancomycin-intermediate S. aureus isolates. The regulatory 3' UTR of the vigR mRNA contributes to vancomycin tolerance and upregulates the autolysin IsaA. Using MS2-affinity purification coupled with RNA sequencing, we find that the vigR 3' UTR also regulates dapE, a succinyl-diaminopimelate desuccinylase required for lysine and peptidoglycan synthesis, suggesting a broader role in controlling cell wall metabolism and vancomycin tolerance...
April 6, 2024: Cell Reports
https://read.qxmd.com/read/38579431/staphylococcus-aureus-nasal-colonization-and-susceptibility-profile-to-antimicrobials-in-hemodialysis-patients-using-a-protocol-of-seven-collections
#7
JOURNAL ARTICLE
Mariana Abou Mourad Ferreira, Pamella Plass Andrade Pires, Kênia Valéria Dos Santos
BACKGROUND: Patients colonized with Staphylococcus aureus in their nasal passages have a higher risk of acquiring infection, especially if they are immunocompromised or have comorbidities such as chronic renal failure undergoing hemodialysis (HD). OBJECTIVE: This study aimed to report the prevalence of nasal carriage of S. aureus among HD patients utilizing a seven-week sampling protocol and to assess the susceptibility of these isolates to various antimicrobial agents...
March 30, 2024: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/38576380/low-risk-staphylococcus-aureus-bacteremia-patients-do-not-require-routine-diagnostic-imaging-a-multicenter-retrospective-cohort-study
#8
JOURNAL ARTICLE
M M C Hendriks, K S A Schweren, A Kleij, M A H Berrevoets, E de Jong, P van Wijngaarden, H S M Ammerlaan, A N Vos, S van Assen, K Slieker, E H Gisolf, M G Netea, J Ten Oever, I J E Kouijzer
BACKGROUND: Risk stratification to categorize patients with Staphylococcus aureus bacteremia (SAB) as low- or high-risk for metastatic infection may direct diagnostic evaluation and enable personalized management. We investigated the frequency of metastatic infections in low-risk SAB patients, their clinical relevance, and whether omission of routine imaging is associated with worse outcomes. METHODS: We performed a retrospective cohort study in seven Dutch hospitals among adult patients with low-risk SAB, defined as hospital-acquired infection without treatment delay, absence of prosthetic material, short duration of bacteremia, and rapid defervescence...
April 5, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38564101/ceftaroline-fosamil-for-the-treatment-of-methicillin-resistant-staphylococcus-aureus-bacteremia-a-real-world-comparative-clinical-outcomes-study
#9
JOURNAL ARTICLE
Jennifer Hammond, Michael Benigno, Nataly Bleibdrey, Wajeeha Ansari, Jennifer L Nguyen
BACKGROUND AND OBJECTIVE: Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia results in substantial morbidity and mortality. As current treatments often lead to unsatisfactory outcomes, evidence guiding alternative treatment options is needed. This study evaluated real-world clinical outcomes of ceftaroline fosamil for the treatment of MRSA bacteremia. METHODS: This retrospective study included adults hospitalized with MRSA bacteremia between 2011 and 2019...
April 2, 2024: Drugs—Real World Outcomes
https://read.qxmd.com/read/38559201/early-initiation-of-ceftaroline-based-combination-therapy-for-methicillin-resistant-staphylococcus-aureus-bacteremia
#10
Addison S Hicks, Mackenzie A Dolan, Megan D Shah, Sarah E Elwood, James A Platts-Mills, Gregory R Madden, Zachary S Elliott, Joshua C Eby
PURPOSE: Monotherapy with vancomycin or daptomycin remains guideline-based care for methicillin-resistant Staphylococcus aureus bacteremia (MRSA-B) despite concerns regarding efficacy. Limited data support potential benefit of combination therapy with ceftaroline as initial therapy. We present an assessment of outcomes of patients initiated on early combination therapy for MRSA-B. METHODS: This was a single-center, retrospective study of adult patients admitted with MRSA-B between July 1, 2017 and April 31, 2023...
March 15, 2024: Research Square
https://read.qxmd.com/read/38529283/vaccination-with-staphylococcal-protein-a-protects-mice-against-systemic-complications-of-skin-infection-recurrences
#11
JOURNAL ARTICLE
Andrea Paola Mandelli, Greta Magri, Marco Tortoli, Stefania Torricelli, Donatello Laera, Fabio Bagnoli, Oretta Finco, Giuliano Bensi, Michela Brazzoli, Emiliano Chiarot
Skin and soft tissue infections (SSTIs) are the most common diseases caused by Staphylococcus aureus ( S. aureus ), which can progress to threatening conditions due to recurrences and systemic complications. Staphylococcal protein A (SpA) is an immunomodulator antigen of S. aureus , which allows bacterial evasion from the immune system by interfering with different types of immune responses to pathogen antigens. Immunization with SpA could potentially unmask the pathogen to the immune system, leading to the production of antibodies that can protect from a second encounter with S...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38527433/utility-of-echocardiogram-in-neutropenic-patients-with-gram-positive-bacteremia-a-retrospective-study
#12
Neta Sternbach, Haim Ben-Zvi, Ofir Wolach, Moshe Yeshurun, Pia Raanani, Dafna Yahav, Liat Shargian
INTRODUCTION: Hemato-oncology patients are vulnerable to bloodstream infections due to immunocompromised state and use of intravascular catheters. Data regarding risk of infective endocarditis (IE) among those with gram positive bacteremia is limited. We aimed to evaluate the incidence of IE among neutropenic hemato-oncology patients, and to explore the yield of echocardiogram in this population. METHODS: we conducted a single retrospective study of all hospitalized hemato-oncology neutropenic patients with gram positive blood cultures between 2007 and 2021...
March 25, 2024: Acta Haematologica
https://read.qxmd.com/read/38523983/rapid-progression-of-aortitis-caused-by-methicillin-sensitive-staphylococcus-aureus-in-a-patient-with-pneumonia-a-case-report
#13
Hideya Itagaki, Tomoya Ooizumi, Chiho Sanada, Yoshinobu Abe, Tomoyuki Endo
Infected aortic aneurysm is a rare but fatal disease that occurs through various mechanisms. In this report, we describe the case of a patient who was hospitalized for acute pneumonia and developed an infected aortic aneurysm in the descending aorta during the hospitalization. A 73-year-old Japanese man presented to the emergency department with a chief complaint of fever. He had a history of chronic renal failure due to nephrosclerosis and was on regular hemodialysis three times a week. The patient presented with an elevated inflammatory response, anemia, and low platelet counts after various tests...
February 2024: Curēus
https://read.qxmd.com/read/38510909/clinical-disease-and-outcomes-of-group-b-streptococcus-bloodstream-infections-at-a-teaching-hospital-in-saudi-arabia-from-2015-to-2022
#14
JOURNAL ARTICLE
Nisreen Bajnaid, Reham Kaki
Background Invasive disease due to group B Streptococcus (GBS) infection in adult males and nonpregnant females can cause various diseases, such as primary bacteremia, endocarditis, skin and soft tissue infection (SSTI), and meningitis. Especially in older people, invasive GBS infection has a high case fatality rate. In Saudi Arabia, little is known about the clinical signs and symptoms of GBS bacteremia and the associated risk factors and mortality rate. Methodology We performed a retrospective study at King Abdulaziz University Hospital in Jeddah, Saudi Arabia, a large tertiary hospital, to investigate clinical disease, potential risk factors, susceptibility patterns, and mortality related to GBS in adult males and nonpregnant females diagnosed with GBS bacteremia...
February 2024: Curēus
https://read.qxmd.com/read/38507229/contemporary-management-of-staphylococcus-aureus-bacteremia-some-additional-considerations-for-clinicians
#15
JOURNAL ARTICLE
George Sakoulas, Erin E Tsou, Matthew Geriak, Logan Vasina
No abstract text is available yet for this article.
March 20, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38497326/daptomycin-dose-optimization-in-pediatric-staphylococcus-aureus-bacteremia-a-pharmacokinetic-pharmacodynamic-investigation
#16
JOURNAL ARTICLE
Katie B Olney, Joel I Howard, David S Burgess
Daptomycin is an antibiotic with Gram-positive activity, including methicillin-resistant Staphylococcus aureus, for which optimal pediatric dosing is unknown. This study aimed to evaluate daptomycin exposures achieved with package label dosing and to identify dosing regimens necessary to enhance efficacy and minimize toxicity in children with S. aureus bacteremia. Monte Carlo simulations were performed to determine probability of target attainment (PTA) for six pediatric age cohorts. Area under the curve to minimum inhibitory concentration ratio (AUC0-24 :MIC) ≥666 was used to determine the PTA for efficacy (PTAE )...
March 18, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38493003/clinical-impact-of-vancomycin-mic-on-outcomes-in-patients-with-coagulase-negative-staphylococcal-bacteremia
#17
JOURNAL ARTICLE
Wade Wheat, Brenda Simiyu, Gabriela Andonie, Lillian Bellfi
PURPOSE: Coagulase-negative staphylococci (CoNS) are Gram-positive organisms that are a known component of normal skin flora and the most common cause of nosocomial bacteremia. For CoNS species, the vancomycin MIC breakpoint for susceptibility set by the Clinical and Laboratory Standards Institute is ≤4 µg/mL. There has been published reports of vancomycin heteroresistance in CoNS with vancomycin MICs of 2 to 4 µg/mL. The aim of this retrospective cohort analysis was to assess the clinical impact of vancomycin MICs <2 µg/mL versus ≥2 µg/mL in adult patients with CoNS bloodstream infections...
March 15, 2024: Clinical Therapeutics
https://read.qxmd.com/read/38487127/daptomycin-and-ceftaroline-combination-therapy-in-complicated-endovascular-infections-caused-by-methicillin-resistant-staphylococcus-epidermidis
#18
JOURNAL ARTICLE
Sílvia Policarpo, Raquel Duro, Nuno R Pereira, Lurdes Santos
Background In complicated endovascular infections by methicillin-resistant Staphylococcus aureus (MRSA) or Staphylococcus epidermidis (MRSE), when first-line therapy with vancomycin (VAN) or daptomycin (DAP) fails, combination therapy with ceftaroline (CFT) and DAP has been shown to be a useful approach as salvage therapy for persistent MRSA bacteremia. Objectives This study aimed to describe experience with daptomycin and ceftaroline combination therapy in MRSE-complicated endovascular infections. Methods A single-center retrospective review of consecutive patients with MRSE-complicated endovascular infections treated with ≥72 hours of DAP+CFT at any time during the course of treatment, from January 1, 2016 to December 31, 2020, at Centro Hospitalar Universitário São João (CHUSJ), Porto, Portugal, was conducted...
February 2024: Curēus
https://read.qxmd.com/read/38482081/a-rare-case-of-iga-vasculitis-in-an-adult-patient-with-mssa-bacteremia-and-prostate-abscess
#19
Maria E Mesalles, Erinolaoluwa F Araoye, Anees Siddiqi, Adrien Janvier
UNLABELLED: IgA vasculitis, previously known as Henoch Schönlein Purpura (HSP), is a disease more common in children and occurs when IgA1 immune complexes attach to the walls of small blood vessels causing inflammation. This case report is of an adult male who presented with a purpuric rash affecting both legs, microhematuria, and knee pain. Blood cultures were positive for Methicillin-sensitive Staphylococcus aureus (MSSA). Computed tomography of the pelvis revealed a prostate abscess...
2024: Journal of Community Hospital Internal Medicine Perspectives
https://read.qxmd.com/read/38482056/chiral-phthalimides-against-penicillin-binding-protein-2a-of-methicillin-resistant-staphylococcus-aureus-molecular-docking-and-in-vitro-analysis
#20
JOURNAL ARTICLE
Aamina Azam Khan, Momin Khan, Sher Wali Khan, Nayyer Siddique, Rimsha Abid, Shandana Zulfiqar, Sidra Rahman, Muhammad Ali
Staphylococcus aureus ( S. aureus ) is a commensal bacterium and an opportunistic pathogen causing a wide variety of infections ranging from localized skin and soft tissue infections to life-threatening severe bacteremia, osteomyelitis, endocarditis, atopic dermatitis, prosthetic joint infection, staphylococcal food poisoning, medical device-related infections, and pneumonia. It is attributed to an acquired resistant gene, mecA , encoding penicillin-binding protein 2a (PBP2a). PBP2a is an essential protein responsible for the resistivity of methicillin-resistant S...
2024: Frontiers in Pharmacology
keyword
keyword
78221
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.